#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	ana	4-1

#Text=Fungal infections are generally perceived as being relatively uncommon , yet are reported to affect more than a billion people .
3-1	17-23	Fungal	event[3]	new[3]	coref	5-1[11_3]
3-2	24-34	infections	event[3]	new[3]	_	_
3-3	35-38	are	_	_	_	_
3-4	39-48	generally	_	_	_	_
3-5	49-58	perceived	_	_	_	_
3-6	59-61	as	_	_	_	_
3-7	62-67	being	_	_	_	_
3-8	68-78	relatively	_	_	_	_
3-9	79-87	uncommon	_	_	_	_
3-10	88-89	,	_	_	_	_
3-11	90-93	yet	_	_	_	_
3-12	94-97	are	_	_	_	_
3-13	98-106	reported	_	_	_	_
3-14	107-109	to	_	_	_	_
3-15	110-116	affect	_	_	_	_
3-16	117-121	more	_	_	_	_
3-17	122-126	than	_	_	_	_
3-18	127-128	a	person[5]	new[5]	_	_
3-19	129-136	billion	abstract|person[5]	new|new[5]	_	_
3-20	137-143	people	person[5]	new[5]	_	_
3-21	144-145	.	_	_	_	_

#Text=This is exacerbated when we consider the alarming global burden of antifungal resistance that we now experience .
4-1	146-150	This	abstract	giv	_	_
4-2	151-153	is	_	_	_	_
4-3	154-165	exacerbated	_	_	_	_
4-4	166-170	when	_	_	_	_
4-5	171-173	we	person	acc	ana	4-15
4-6	174-182	consider	_	_	_	_
4-7	183-186	the	abstract[8]	new[8]	_	_
4-8	187-195	alarming	abstract[8]	new[8]	_	_
4-9	196-202	global	abstract[8]	new[8]	_	_
4-10	203-209	burden	abstract[8]	new[8]	_	_
4-11	210-212	of	abstract[8]	new[8]	_	_
4-12	213-223	antifungal	abstract[8]|abstract[9]	new[8]|new[9]	coref	7-34[28_9]
4-13	224-234	resistance	abstract[8]|abstract[9]	new[8]|new[9]	_	_
4-14	235-239	that	_	_	_	_
4-15	240-242	we	person	giv	ana	5-3
4-16	243-246	now	_	_	_	_
4-17	247-257	experience	_	_	_	_
4-18	258-259	.	_	_	_	_

#Text=Many infections we believe to be of bacterial origin are in fact fungal .
5-1	260-264	Many	event[11]	giv[11]	coref	10-4[37_11]
5-2	265-275	infections	event[11]	giv[11]	_	_
5-3	276-278	we	person	giv	ana	10-2
5-4	279-286	believe	_	_	_	_
5-5	287-289	to	_	_	_	_
5-6	290-292	be	_	_	_	_
5-7	293-295	of	_	_	_	_
5-8	296-305	bacterial	abstract[13]	new[13]	_	_
5-9	306-312	origin	abstract[13]	new[13]	_	_
5-10	313-316	are	_	_	_	_
5-11	317-319	in	_	_	_	_
5-12	320-324	fact	person[14]	new[14]	_	_
5-13	325-331	fungal	person[14]	new[14]	_	_
5-14	332-333	.	_	_	_	_

#Text=Indeed , the yeast Candida albicans is a ubiquitous human commensal , but with opportunistic tendencies .
6-1	334-340	Indeed	_	_	_	_
6-2	341-342	,	_	_	_	_
6-3	343-346	the	substance[15]	new[15]	ana	7-1[0_15]
6-4	347-352	yeast	substance[15]	new[15]	_	_
6-5	353-360	Candida	_	_	_	_
6-6	361-369	albicans	_	_	_	_
6-7	370-372	is	_	_	_	_
6-8	373-374	a	_	_	_	_
6-9	375-385	ubiquitous	_	_	_	_
6-10	386-391	human	_	_	_	_
6-11	392-401	commensal	_	_	_	_
6-12	402-403	,	_	_	_	_
6-13	404-407	but	_	_	_	_
6-14	408-412	with	_	_	_	_
6-15	413-426	opportunistic	abstract[16]	new[16]	_	_
6-16	427-437	tendencies	abstract[16]	new[16]	_	_
6-17	438-439	.	_	_	_	_

#Text=Its capacity to morphologically transition from yeast to hyphal cells enables it to react dynamically , both in evasion of host immunity and in its ability to readily form biofilm structures that impact increased antifungal resistance .
7-1	440-443	Its	substance|abstract[18]	giv|new[18]	coref|coref|coref|coref	7-7[19_0]|7-25[25_18]|7-7[19_0]|7-25[25_18]
7-2	444-452	capacity	abstract[18]	new[18]	_	_
7-3	453-455	to	_	_	_	_
7-4	456-471	morphologically	_	_	_	_
7-5	472-482	transition	_	_	_	_
7-6	483-487	from	_	_	_	_
7-7	488-493	yeast	substance[19]	giv[19]	ana	7-12[0_19]
7-8	494-496	to	substance[19]	giv[19]	_	_
7-9	497-503	hyphal	substance[19]|object[20]	giv[19]|new[20]	coref	22-8[119_20]
7-10	504-509	cells	substance[19]|object[20]	giv[19]|new[20]	_	_
7-11	510-517	enables	_	_	_	_
7-12	518-520	it	substance	giv	ana	7-25
7-13	521-523	to	_	_	_	_
7-14	524-529	react	_	_	_	_
7-15	530-541	dynamically	_	_	_	_
7-16	542-543	,	_	_	_	_
7-17	544-548	both	_	_	_	_
7-18	549-551	in	_	_	_	_
7-19	552-559	evasion	abstract[22]	new[22]	_	_
7-20	560-562	of	abstract[22]	new[22]	_	_
7-21	563-567	host	abstract[22]|abstract[23]	new[22]|new[23]	_	_
7-22	568-576	immunity	abstract[22]|abstract[23]	new[22]|new[23]	_	_
7-23	577-580	and	_	_	_	_
7-24	581-583	in	_	_	_	_
7-25	584-587	its	plant|abstract[25]	giv|giv[25]	coref|coref|coref|coref	17-4[82_0]|22-5[118_25]|17-4[82_0]|22-5[118_25]
7-26	588-595	ability	abstract[25]	giv[25]	_	_
7-27	596-598	to	_	_	_	_
7-28	599-606	readily	_	_	_	_
7-29	607-611	form	_	_	_	_
7-30	612-619	biofilm	object|object[27]	new|new[27]	coref|coref	21-16|21-16
7-31	620-630	structures	object[27]	new[27]	_	_
7-32	631-635	that	_	_	_	_
7-33	636-642	impact	_	_	_	_
7-34	643-652	increased	abstract[28]	giv[28]	_	_
7-35	653-663	antifungal	abstract[28]	giv[28]	_	_
7-36	664-674	resistance	abstract[28]	giv[28]	_	_
7-37	675-676	.	_	_	_	_

#Text=C. albicans
8-1	677-679	C.	person[29]	new[29]	coref	15-1[78_29]
8-2	680-688	albicans	person[29]	new[29]	_	_

#Text=frequently resides in the oral cavity as a biofilm forming microorganism , interacting with other oral microbiota and the host .
9-1	689-699	frequently	_	_	_	_
9-2	700-707	resides	_	_	_	_
9-3	708-710	in	_	_	_	_
9-4	711-714	the	place[30]	new[30]	_	_
9-5	715-719	oral	place[30]	new[30]	_	_
9-6	720-726	cavity	place[30]	new[30]	_	_
9-7	727-729	as	_	_	_	_
9-8	730-731	a	_	_	_	_
9-9	732-739	biofilm	_	_	_	_
9-10	740-747	forming	_	_	_	_
9-11	748-761	microorganism	object	new	_	_
9-12	762-763	,	_	_	_	_
9-13	764-775	interacting	_	_	_	_
9-14	776-780	with	_	_	_	_
9-15	781-786	other	object[32]	new[32]	coref	13-26[66_32]
9-16	787-791	oral	object[32]	new[32]	_	_
9-17	792-802	microbiota	object[32]	new[32]	_	_
9-18	803-806	and	_	_	_	_
9-19	807-810	the	person[33]	new[33]	coref	22-12[0_33]
9-20	811-815	host	person[33]	new[33]	_	_
9-21	816-817	.	_	_	_	_

#Text=When we consider root canal infections , pathogenic yeasts have also been isolated from teeth associated with primary apical periodontitis and post-treatment disease .
10-1	818-822	When	_	_	_	_
10-2	823-825	we	person	giv	_	_
10-3	826-834	consider	_	_	_	_
10-4	835-839	root	object|event[37]	new|giv[37]	coref|coref|coref|coref	16-8[80_37]|27-5|16-8[80_37]|27-5
10-5	840-845	canal	place|event[37]	new|giv[37]	coref	14-17
10-6	846-856	infections	event[37]	giv[37]	_	_
10-7	857-858	,	_	_	_	_
10-8	859-869	pathogenic	object[38]	new[38]	coref	21-3[108_38]
10-9	870-876	yeasts	object[38]	new[38]	_	_
10-10	877-881	have	_	_	_	_
10-11	882-886	also	_	_	_	_
10-12	887-891	been	_	_	_	_
10-13	892-900	isolated	_	_	_	_
10-14	901-905	from	_	_	_	_
10-15	906-911	teeth	object	new	coref	11-37[51_0]
10-16	912-922	associated	_	_	_	_
10-17	923-927	with	_	_	_	_
10-18	928-935	primary	object[40]	new[40]	coref	23-30[132_40]
10-19	936-942	apical	object[40]	new[40]	_	_
10-20	943-956	periodontitis	object[40]	new[40]	_	_
10-21	957-960	and	_	_	_	_
10-22	961-975	post-treatment	abstract[41]	new[41]	_	_
10-23	976-983	disease	abstract[41]	new[41]	_	_
10-24	984-985	.	_	_	_	_

#Text=Dental pulp is generally a sterile tissue containing nerves and vascular tissues that are connected to the surrounding periradicular tissues , though recent studies appear to suggest the presence of bacterial DNA in the pulp of pristine healthy teeth .
11-1	986-992	Dental	object[42]	new[42]	coref	11-4[43_42]
11-2	993-997	pulp	object[42]	new[42]	_	_
11-3	998-1000	is	_	_	_	_
11-4	1001-1010	generally	object[43]	giv[43]	coref	11-34[50_43]
11-5	1011-1012	a	object[43]	giv[43]	_	_
11-6	1013-1020	sterile	object[43]	giv[43]	_	_
11-7	1021-1027	tissue	object[43]	giv[43]	_	_
11-8	1028-1038	containing	_	_	_	_
11-9	1039-1045	nerves	abstract	new	_	_
11-10	1046-1049	and	_	_	_	_
11-11	1050-1058	vascular	object[45]	new[45]	coref	11-17[46_45]
11-12	1059-1066	tissues	object[45]	new[45]	_	_
11-13	1067-1071	that	_	_	_	_
11-14	1072-1075	are	_	_	_	_
11-15	1076-1085	connected	_	_	_	_
11-16	1086-1088	to	_	_	_	_
11-17	1089-1092	the	object[46]	giv[46]	coref	12-12[55_46]
11-18	1093-1104	surrounding	object[46]	giv[46]	_	_
11-19	1105-1118	periradicular	object[46]	giv[46]	_	_
11-20	1119-1126	tissues	object[46]	giv[46]	_	_
11-21	1127-1128	,	_	_	_	_
11-22	1129-1135	though	_	_	_	_
11-23	1136-1142	recent	abstract[47]	new[47]	_	_
11-24	1143-1150	studies	abstract[47]	new[47]	_	_
11-25	1151-1157	appear	_	_	_	_
11-26	1158-1160	to	_	_	_	_
11-27	1161-1168	suggest	_	_	_	_
11-28	1169-1172	the	abstract[48]	new[48]	_	_
11-29	1173-1181	presence	abstract[48]	new[48]	_	_
11-30	1182-1184	of	abstract[48]	new[48]	_	_
11-31	1185-1194	bacterial	abstract[48]|substance[49]	new[48]|new[49]	_	_
11-32	1195-1198	DNA	abstract[48]|substance[49]	new[48]|new[49]	_	_
11-33	1199-1201	in	abstract[48]|substance[49]	new[48]|new[49]	_	_
11-34	1202-1205	the	abstract[48]|substance[49]|object[50]	new[48]|new[49]|giv[50]	coref	12-1[52_50]
11-35	1206-1210	pulp	abstract[48]|substance[49]|object[50]	new[48]|new[49]|giv[50]	_	_
11-36	1211-1213	of	abstract[48]|substance[49]|object[50]	new[48]|new[49]|giv[50]	_	_
11-37	1214-1222	pristine	abstract[48]|substance[49]|object[50]|object[51]	new[48]|new[49]|giv[50]|giv[51]	_	_
11-38	1223-1230	healthy	abstract[48]|substance[49]|object[50]|object[51]	new[48]|new[49]|giv[50]|giv[51]	_	_
11-39	1231-1236	teeth	abstract[48]|substance[49]|object[50]|object[51]	new[48]|new[49]|giv[50]|giv[51]	_	_
11-40	1237-1238	.	_	_	_	_

#Text=The pulp is protected from the oral microbiome by layers of mineralised tissues ( dentin , enamel and cementum ) .
12-1	1239-1242	The	object[52]	giv[52]	coref	13-31[68_52]
12-2	1243-1247	pulp	object[52]	giv[52]	_	_
12-3	1248-1250	is	_	_	_	_
12-4	1251-1260	protected	_	_	_	_
12-5	1261-1265	from	_	_	_	_
12-6	1266-1269	the	object[53]	new[53]	_	_
12-7	1270-1274	oral	object[53]	new[53]	_	_
12-8	1275-1285	microbiome	object[53]	new[53]	_	_
12-9	1286-1288	by	_	_	_	_
12-10	1289-1295	layers	object[54]	new[54]	_	_
12-11	1296-1298	of	object[54]	new[54]	_	_
12-12	1299-1310	mineralised	object[54]|object[55]	new[54]|giv[55]	appos	12-15[56_55]
12-13	1311-1318	tissues	object[54]|object[55]	new[54]|giv[55]	_	_
12-14	1319-1320	(	_	_	_	_
12-15	1321-1327	dentin	object[56]	giv[56]	coref	13-3[59_56]
12-16	1328-1329	,	object[56]	giv[56]	_	_
12-17	1330-1336	enamel	object[56]	giv[56]	_	_
12-18	1337-1340	and	object[56]	giv[56]	_	_
12-19	1341-1349	cementum	object[56]|substance	giv[56]|new	_	_
12-20	1350-1351	)	_	_	_	_
12-21	1352-1353	.	_	_	_	_

#Text=Breach to these tissues , as a result of dental caries , tooth fractures or cracks , can expose the dentin and provide routes for oral microbiota to ingress towards the pulp .
13-1	1354-1360	Breach	abstract[58]	new[58]	_	_
13-2	1361-1363	to	abstract[58]	new[58]	_	_
13-3	1364-1369	these	abstract[58]|object[59]	new[58]|giv[59]	coref	25-23[146_59]
13-4	1370-1377	tissues	abstract[58]|object[59]	new[58]|giv[59]	_	_
13-5	1378-1379	,	abstract[58]	new[58]	_	_
13-6	1380-1382	as	abstract[58]	new[58]	_	_
13-7	1383-1384	a	abstract[58]	new[58]	_	_
13-8	1385-1391	result	abstract[58]	new[58]	_	_
13-9	1392-1394	of	abstract[58]	new[58]	_	_
13-10	1395-1401	dental	abstract[58]|object[60]	new[58]|new[60]	coref	20-45[0_60]
13-11	1402-1408	caries	abstract[58]|object[60]	new[58]|new[60]	_	_
13-12	1409-1410	,	abstract[58]	new[58]	_	_
13-13	1411-1416	tooth	abstract[58]|object|event[62]	new[58]|new|new[62]	_	_
13-14	1417-1426	fractures	abstract[58]|event[62]	new[58]|new[62]	_	_
13-15	1427-1429	or	abstract[58]	new[58]	_	_
13-16	1430-1436	cracks	abstract[58]|abstract	new[58]|new	coref	20-15[95_0]
13-17	1437-1438	,	_	_	_	_
13-18	1439-1442	can	_	_	_	_
13-19	1443-1449	expose	_	_	_	_
13-20	1450-1453	the	object[64]	new[64]	coref	28-28[0_64]
13-21	1454-1460	dentin	object[64]	new[64]	_	_
13-22	1461-1464	and	_	_	_	_
13-23	1465-1472	provide	_	_	_	_
13-24	1473-1479	routes	place[65]	new[65]	_	_
13-25	1480-1483	for	place[65]	new[65]	_	_
13-26	1484-1488	oral	place[65]|object[66]	new[65]|giv[66]	_	_
13-27	1489-1499	microbiota	place[65]|object[66]	new[65]|giv[66]	_	_
13-28	1500-1502	to	place[65]|object[66]	new[65]|giv[66]	_	_
13-29	1503-1510	ingress	place[65]|object[66]|abstract[67]	new[65]|giv[66]|new[67]	_	_
13-30	1511-1518	towards	place[65]|object[66]|abstract[67]	new[65]|giv[66]|new[67]	_	_
13-31	1519-1522	the	place[65]|object[66]|abstract[67]|object[68]	new[65]|giv[66]|new[67]|giv[68]	coref	14-4[0_68]
13-32	1523-1527	pulp	place[65]|object[66]|abstract[67]|object[68]	new[65]|giv[66]|new[67]|giv[68]	_	_
13-33	1528-1529	.	_	_	_	_

#Text=Another route of pulp infection is the direct invasion of microorganisms to the pulp during root canal treatment during substandard clinical procedures .
14-1	1530-1537	Another	event[69]	new[69]	coref	14-7[72_69]
14-2	1538-1543	route	event[69]	new[69]	_	_
14-3	1544-1546	of	event[69]	new[69]	_	_
14-4	1547-1551	pulp	event[69]|object|abstract[71]	new[69]|giv|new[71]	coref|coref	14-13[74_0]|14-13[74_0]
14-5	1552-1561	infection	event[69]|abstract[71]	new[69]|new[71]	_	_
14-6	1562-1564	is	_	_	_	_
14-7	1565-1568	the	event[72]	giv[72]	coref	20-4[93_72]
14-8	1569-1575	direct	event[72]	giv[72]	_	_
14-9	1576-1584	invasion	event[72]	giv[72]	_	_
14-10	1585-1587	of	event[72]	giv[72]	_	_
14-11	1588-1602	microorganisms	event[72]|object[73]	giv[72]|new[73]	coref	25-9[141_73]
14-12	1603-1605	to	event[72]|object[73]	giv[72]|new[73]	_	_
14-13	1606-1609	the	event[72]|object[73]|object[74]	giv[72]|new[73]|giv[74]	coref	28-22[0_74]
14-14	1610-1614	pulp	event[72]|object[73]|object[74]	giv[72]|new[73]|giv[74]	_	_
14-15	1615-1621	during	event[72]	giv[72]	_	_
14-16	1622-1626	root	event[72]|event[76]	giv[72]|new[76]	coref	24-1[135_76]
14-17	1627-1632	canal	event[72]|place|event[76]	giv[72]|giv|new[76]	coref	22-23[124_0]
14-18	1633-1642	treatment	event[72]|event[76]	giv[72]|new[76]	_	_
14-19	1643-1649	during	event[72]|event[76]	giv[72]|new[76]	_	_
14-20	1650-1661	substandard	event[72]|event[76]|abstract[77]	giv[72]|new[76]|new[77]	_	_
14-21	1662-1670	clinical	event[72]|event[76]|abstract[77]	giv[72]|new[76]|new[77]	_	_
14-22	1671-1681	procedures	event[72]|event[76]|abstract[77]	giv[72]|new[76]|new[77]	_	_
14-23	1682-1683	.	_	_	_	_

#Text=C. albicans
15-1	1684-1686	C.	person[78]	giv[78]	coref	19-4[89_78]
15-2	1687-1695	albicans	person[78]	giv[78]	_	_

#Text=is the most frequently isolated species in endodontic infections .
16-1	1696-1698	is	_	_	_	_
16-2	1699-1702	the	abstract[79]	new[79]	_	_
16-3	1703-1707	most	abstract[79]	new[79]	_	_
16-4	1708-1718	frequently	abstract[79]	new[79]	_	_
16-5	1719-1727	isolated	abstract[79]	new[79]	_	_
16-6	1728-1735	species	abstract[79]	new[79]	_	_
16-7	1736-1738	in	abstract[79]	new[79]	_	_
16-8	1739-1749	endodontic	abstract[79]|event[80]	new[79]|giv[80]	coref	17-6[83_80]
16-9	1750-1760	infections	abstract[79]|event[80]	new[79]|giv[80]	_	_
16-10	1761-1762	.	_	_	_	_

#Text=The prevalence of yeast in persistent infections is higher than that in primary infections .
17-1	1763-1766	The	abstract[81]	new[81]	coref	18-9[86_81]
17-2	1767-1777	prevalence	abstract[81]	new[81]	_	_
17-3	1778-1780	of	abstract[81]	new[81]	_	_
17-4	1781-1786	yeast	abstract[81]|substance[82]	new[81]|giv[82]	coref	21-24[0_82]
17-5	1787-1789	in	abstract[81]|substance[82]	new[81]|giv[82]	_	_
17-6	1790-1800	persistent	abstract[81]|substance[82]|event[83]	new[81]|giv[82]|giv[83]	coref	17-13[84_83]
17-7	1801-1811	infections	abstract[81]|substance[82]|event[83]	new[81]|giv[82]|giv[83]	_	_
17-8	1812-1814	is	_	_	_	_
17-9	1815-1821	higher	_	_	_	_
17-10	1822-1826	than	_	_	_	_
17-11	1827-1831	that	_	_	_	_
17-12	1832-1834	in	_	_	_	_
17-13	1835-1842	primary	event[84]	giv[84]	coref	18-16[87_84]
17-14	1843-1853	infections	event[84]	giv[84]	_	_
17-15	1854-1855	.	_	_	_	_

#Text=However , two recent systematic reviews found that C. albicans prevalence does vary significantly between primary and secondary endodontic infections .
18-1	1856-1863	However	_	_	_	_
18-2	1864-1865	,	_	_	_	_
18-3	1866-1869	two	abstract[85]	new[85]	_	_
18-4	1870-1876	recent	abstract[85]	new[85]	_	_
18-5	1877-1887	systematic	abstract[85]	new[85]	_	_
18-6	1888-1895	reviews	abstract[85]	new[85]	_	_
18-7	1896-1901	found	_	_	_	_
18-8	1902-1906	that	_	_	_	_
18-9	1907-1909	C.	abstract[86]	giv[86]	_	_
18-10	1910-1918	albicans	abstract[86]	giv[86]	_	_
18-11	1919-1929	prevalence	abstract[86]	giv[86]	_	_
18-12	1930-1934	does	_	_	_	_
18-13	1935-1939	vary	_	_	_	_
18-14	1940-1953	significantly	_	_	_	_
18-15	1954-1961	between	_	_	_	_
18-16	1962-1969	primary	event[87]	giv[87]	coref	24-13[139_87]
18-17	1970-1973	and	event[87]	giv[87]	_	_
18-18	1974-1983	secondary	event[87]	giv[87]	_	_
18-19	1984-1994	endodontic	event[87]	giv[87]	_	_
18-20	1995-2005	infections	event[87]	giv[87]	_	_
18-21	2006-2007	.	_	_	_	_

#Text=In this environment C. albicans can colonise dentinal walls and penetrate into dentinal tubules .
19-1	2008-2010	In	_	_	_	_
19-2	2011-2015	this	abstract[88]	new[88]	_	_
19-3	2016-2027	environment	abstract[88]	new[88]	_	_
19-4	2028-2030	C.	animal[89]	giv[89]	coref	29-28[181_89]
19-5	2031-2039	albicans	animal[89]	giv[89]	_	_
19-6	2040-2043	can	_	_	_	_
19-7	2044-2052	colonise	_	_	_	_
19-8	2053-2061	dentinal	object[90]	new[90]	coref	26-18[154_90]
19-9	2062-2067	walls	object[90]	new[90]	_	_
19-10	2068-2071	and	_	_	_	_
19-11	2072-2081	penetrate	_	_	_	_
19-12	2082-2086	into	_	_	_	_
19-13	2087-2095	dentinal	object[91]	new[91]	coref	20-40[0_91]
19-14	2096-2103	tubules	object[91]	new[91]	_	_
19-15	2104-2105	.	_	_	_	_

#Text=The route of fungal invasion to the root canals is likely to be through cracks or via leaking restoration , though the diameter of hyphae , which is 1.9 – 2.6 µm , cannot exclude the possibility of dentinal tubules invasion especially in deep caries lesions .
20-1	2106-2109	The	abstract[92]	new[92]	_	_
20-2	2110-2115	route	abstract[92]	new[92]	_	_
20-3	2116-2118	of	abstract[92]	new[92]	_	_
20-4	2119-2125	fungal	abstract[92]|event[93]	new[92]|giv[93]	coref	20-39[104_93]
20-5	2126-2134	invasion	abstract[92]|event[93]	new[92]|giv[93]	_	_
20-6	2135-2137	to	abstract[92]|event[93]	new[92]|giv[93]	_	_
20-7	2138-2141	the	abstract[92]|event[93]|place[94]	new[92]|giv[93]|new[94]	coref	23-19[130_94]
20-8	2142-2146	root	abstract[92]|event[93]|place[94]	new[92]|giv[93]|new[94]	_	_
20-9	2147-2153	canals	abstract[92]|event[93]|place[94]	new[92]|giv[93]|new[94]	_	_
20-10	2154-2156	is	_	_	_	_
20-11	2157-2163	likely	_	_	_	_
20-12	2164-2166	to	_	_	_	_
20-13	2167-2169	be	_	_	_	_
20-14	2170-2177	through	_	_	_	_
20-15	2178-2184	cracks	abstract[95]	giv[95]	_	_
20-16	2185-2187	or	abstract[95]	giv[95]	_	_
20-17	2188-2191	via	abstract[95]	giv[95]	_	_
20-18	2192-2199	leaking	abstract[95]	giv[95]	_	_
20-19	2200-2211	restoration	abstract[95]|abstract	giv[95]|new	_	_
20-20	2212-2213	,	_	_	_	_
20-21	2214-2220	though	_	_	_	_
20-22	2221-2224	the	quantity[97]	new[97]	_	_
20-23	2225-2233	diameter	quantity[97]	new[97]	_	_
20-24	2234-2236	of	quantity[97]	new[97]	_	_
20-25	2237-2243	hyphae	quantity[97]|object	new[97]|new	_	_
20-26	2244-2245	,	_	_	_	_
20-27	2246-2251	which	_	_	_	_
20-28	2252-2254	is	_	_	_	_
20-29	2255-2258	1.9	quantity[99]	new[99]	_	_
20-30	2259-2260	–	quantity[99]	new[99]	_	_
20-31	2261-2264	2.6	quantity[99]|quantity	new[99]|new	_	_
20-32	2265-2267	µm	quantity[99]|person	new[99]|new	_	_
20-33	2268-2269	,	_	_	_	_
20-34	2270-2276	cannot	_	_	_	_
20-35	2277-2284	exclude	_	_	_	_
20-36	2285-2288	the	abstract[102]	new[102]	_	_
20-37	2289-2300	possibility	abstract[102]	new[102]	_	_
20-38	2301-2303	of	abstract[102]	new[102]	_	_
20-39	2304-2312	dentinal	abstract[102]|event[104]	new[102]|giv[104]	_	_
20-40	2313-2320	tubules	abstract[102]|object|event[104]	new[102]|giv|giv[104]	_	_
20-41	2321-2329	invasion	abstract[102]|event[104]	new[102]|giv[104]	_	_
20-42	2330-2340	especially	object[106]	new[106]	_	_
20-43	2341-2343	in	object[106]	new[106]	_	_
20-44	2344-2348	deep	object[106]	new[106]	_	_
20-45	2349-2355	caries	object|object[106]	giv|new[106]	_	_
20-46	2356-2363	lesions	object[106]	new[106]	_	_
20-47	2364-2365	.	_	_	_	_

#Text=Here , candida yeasts are capable of coalescing with one another in the form of biofilm , which is a multicellular community of yeast and hyphal forms encased in polymeric glue .
21-1	2366-2370	Here	_	_	_	_
21-2	2371-2372	,	_	_	_	_
21-3	2373-2380	candida	substance|object[108]	new|giv[108]	_	_
21-4	2381-2387	yeasts	object[108]	giv[108]	_	_
21-5	2388-2391	are	_	_	_	_
21-6	2392-2399	capable	_	_	_	_
21-7	2400-2402	of	_	_	_	_
21-8	2403-2413	coalescing	_	_	_	_
21-9	2414-2418	with	_	_	_	_
21-10	2419-2422	one	object	new	_	_
21-11	2423-2430	another	_	_	_	_
21-12	2431-2433	in	_	_	_	_
21-13	2434-2437	the	substance[110]	new[110]	_	_
21-14	2438-2442	form	substance[110]	new[110]	_	_
21-15	2443-2445	of	substance[110]	new[110]	_	_
21-16	2446-2453	biofilm	substance[110]|substance	new[110]|giv	coref	22-2
21-17	2454-2455	,	_	_	_	_
21-18	2456-2461	which	_	_	_	_
21-19	2462-2464	is	_	_	_	_
21-20	2465-2466	a	person[112]	new[112]	_	_
21-21	2467-2480	multicellular	person[112]	new[112]	_	_
21-22	2481-2490	community	person[112]	new[112]	_	_
21-23	2491-2493	of	person[112]	new[112]	_	_
21-24	2494-2499	yeast	person[112]|substance	new[112]|giv	coref	32-29[207_0]
21-25	2500-2503	and	person[112]	new[112]	_	_
21-26	2504-2510	hyphal	person[112]|substance[114]	new[112]|new[114]	_	_
21-27	2511-2516	forms	person[112]|substance[114]	new[112]|new[114]	_	_
21-28	2517-2524	encased	_	_	_	_
21-29	2525-2527	in	_	_	_	_
21-30	2528-2537	polymeric	substance[115]	new[115]	_	_
21-31	2538-2542	glue	substance[115]	new[115]	_	_
21-32	2543-2544	.	_	_	_	_

#Text=The biofilm lifestyle enhances the ability of the cells to withstand host and antifungal factors , ultimately contributing to its persistence within the root canal .
22-1	2545-2548	The	abstract[117]	new[117]	_	_
22-2	2549-2556	biofilm	abstract|abstract[117]	giv|new[117]	coref	26-15[152_0]
22-3	2557-2566	lifestyle	abstract[117]	new[117]	_	_
22-4	2567-2575	enhances	_	_	_	_
22-5	2576-2579	the	abstract[118]	giv[118]	ana	22-20[0_118]
22-6	2580-2587	ability	abstract[118]	giv[118]	_	_
22-7	2588-2590	of	abstract[118]	giv[118]	_	_
22-8	2591-2594	the	abstract[118]|object[119]	giv[118]|giv[119]	_	_
22-9	2595-2600	cells	abstract[118]|object[119]	giv[118]|giv[119]	_	_
22-10	2601-2603	to	_	_	_	_
22-11	2604-2613	withstand	_	_	_	_
22-12	2614-2618	host	person	giv	_	_
22-13	2619-2622	and	_	_	_	_
22-14	2623-2633	antifungal	abstract[121]	new[121]	_	_
22-15	2634-2641	factors	abstract[121]	new[121]	_	_
22-16	2642-2643	,	_	_	_	_
22-17	2644-2654	ultimately	_	_	_	_
22-18	2655-2667	contributing	_	_	_	_
22-19	2668-2670	to	_	_	_	_
22-20	2671-2674	its	abstract|abstract[123]	giv|new[123]	coref|coref	35-5[234_0]|35-5[234_0]
22-21	2675-2686	persistence	abstract[123]	new[123]	_	_
22-22	2687-2693	within	abstract[123]	new[123]	_	_
22-23	2694-2697	the	abstract[123]|place[124]	new[123]|giv[124]	coref	23-10[0_124]
22-24	2698-2702	root	abstract[123]|place[124]	new[123]|giv[124]	_	_
22-25	2703-2708	canal	abstract[123]|place[124]	new[123]|giv[124]	_	_
22-26	2709-2710	.	_	_	_	_

#Text=This phenotype , along with the complexity of root canal system , particularly in the apical third of root canals , are thought to be the major causes of treatment-resistant apical periodontitis .
23-1	2711-2715	This	abstract[125]	new[125]	_	_
23-2	2716-2725	phenotype	abstract[125]	new[125]	_	_
23-3	2726-2727	,	abstract[125]	new[125]	_	_
23-4	2728-2733	along	abstract[125]|abstract[126]	new[125]|new[126]	_	_
23-5	2734-2738	with	abstract[125]|abstract[126]	new[125]|new[126]	_	_
23-6	2739-2742	the	abstract[125]|abstract[126]	new[125]|new[126]	_	_
23-7	2743-2753	complexity	abstract[125]|abstract[126]	new[125]|new[126]	_	_
23-8	2754-2756	of	abstract[125]|abstract[126]	new[125]|new[126]	_	_
23-9	2757-2761	root	abstract[125]|abstract[126]|place[128]	new[125]|new[126]|new[128]	coref	25-11[143_128]
23-10	2762-2767	canal	abstract[125]|abstract[126]|place|place[128]	new[125]|new[126]|giv|new[128]	coref	24-2
23-11	2768-2774	system	abstract[125]|abstract[126]|place[128]	new[125]|new[126]|new[128]	_	_
23-12	2775-2776	,	abstract[125]|abstract[126]	new[125]|new[126]	_	_
23-13	2777-2789	particularly	abstract[125]|abstract[126]|quantity[129]	new[125]|new[126]|new[129]	_	_
23-14	2790-2792	in	abstract[125]|abstract[126]|quantity[129]	new[125]|new[126]|new[129]	_	_
23-15	2793-2796	the	abstract[125]|abstract[126]|quantity[129]	new[125]|new[126]|new[129]	_	_
23-16	2797-2803	apical	abstract[125]|abstract[126]|quantity[129]	new[125]|new[126]|new[129]	_	_
23-17	2804-2809	third	abstract[125]|abstract[126]|quantity[129]	new[125]|new[126]|new[129]	_	_
23-18	2810-2812	of	abstract[125]|abstract[126]|quantity[129]	new[125]|new[126]|new[129]	_	_
23-19	2813-2817	root	abstract[125]|abstract[126]|quantity[129]|place[130]	new[125]|new[126]|new[129]|giv[130]	coref	27-25[162_130]
23-20	2818-2824	canals	abstract[125]|abstract[126]|quantity[129]|place[130]	new[125]|new[126]|new[129]|giv[130]	_	_
23-21	2825-2826	,	_	_	_	_
23-22	2827-2830	are	_	_	_	_
23-23	2831-2838	thought	_	_	_	_
23-24	2839-2841	to	_	_	_	_
23-25	2842-2844	be	_	_	_	_
23-26	2845-2848	the	abstract[131]	new[131]	_	_
23-27	2849-2854	major	abstract[131]	new[131]	_	_
23-28	2855-2861	causes	abstract[131]	new[131]	_	_
23-29	2862-2864	of	abstract[131]	new[131]	_	_
23-30	2865-2884	treatment-resistant	abstract[131]|object[132]	new[131]|giv[132]	_	_
23-31	2885-2891	apical	abstract[131]|object[132]	new[131]|giv[132]	_	_
23-32	2892-2905	periodontitis	abstract[131]|object[132]	new[131]|giv[132]	_	_
23-33	2906-2907	.	_	_	_	_

#Text=Root canal treatment ( RCT ) is the treatment of choice for these endodontic infections .
24-1	2908-2912	Root	person|event[135]	new|giv[135]	appos|appos	24-5[0_135]|24-5[0_135]
24-2	2913-2918	canal	place|event[135]	giv|giv[135]	coref	25-13
24-3	2919-2928	treatment	event[135]	giv[135]	_	_
24-4	2929-2930	(	_	_	_	_
24-5	2931-2934	RCT	event	giv	coref	24-8[137_0]
24-6	2935-2936	)	_	_	_	_
24-7	2937-2939	is	_	_	_	_
24-8	2940-2943	the	event[137]	giv[137]	coref	25-1[0_137]
24-9	2944-2953	treatment	event[137]	giv[137]	_	_
24-10	2954-2956	of	event[137]	giv[137]	_	_
24-11	2957-2963	choice	event[137]|abstract[138]	giv[137]|new[138]	_	_
24-12	2964-2967	for	event[137]|abstract[138]	giv[137]|new[138]	_	_
24-13	2968-2973	these	event[137]|abstract[138]|event[139]	giv[137]|new[138]|giv[139]	coref	37-17[256_139]
24-14	2974-2984	endodontic	event[137]|abstract[138]|event[139]	giv[137]|new[138]|giv[139]	_	_
24-15	2985-2995	infections	event[137]|abstract[138]|event[139]	giv[137]|new[138]|giv[139]	_	_
24-16	2996-2997	.	_	_	_	_

#Text=RCT aims to : ( 1 ) eliminate microorganisms from the root canal system to a level that promotes the healing of periradicular tissues , and ( 2 ) provide a three-dimensional hermetic seal to prevent reinfection .
25-1	2998-3001	RCT	event	giv	coref	26-9
25-2	3002-3006	aims	_	_	_	_
25-3	3007-3009	to	_	_	_	_
25-4	3010-3011	:	_	_	_	_
25-5	3012-3013	(	_	_	_	_
25-6	3014-3015	1	_	_	_	_
25-7	3016-3017	)	_	_	_	_
25-8	3018-3027	eliminate	_	_	_	_
25-9	3028-3042	microorganisms	object[141]	giv[141]	coref	29-24[0_141]
25-10	3043-3047	from	object[141]	giv[141]	_	_
25-11	3048-3051	the	object[141]|place[143]	giv[141]|giv[143]	_	_
25-12	3052-3056	root	object[141]|place[143]	giv[141]|giv[143]	_	_
25-13	3057-3062	canal	object[141]|place|place[143]	giv[141]|giv|giv[143]	coref	26-20
25-14	3063-3069	system	object[141]|place[143]	giv[141]|giv[143]	_	_
25-15	3070-3072	to	object[141]|place[143]	giv[141]|giv[143]	_	_
25-16	3073-3074	a	object[141]|place[143]|abstract[144]	giv[141]|giv[143]|new[144]	_	_
25-17	3075-3080	level	object[141]|place[143]|abstract[144]	giv[141]|giv[143]|new[144]	_	_
25-18	3081-3085	that	_	_	_	_
25-19	3086-3094	promotes	_	_	_	_
25-20	3095-3098	the	event[145]	new[145]	_	_
25-21	3099-3106	healing	event[145]	new[145]	_	_
25-22	3107-3109	of	event[145]	new[145]	_	_
25-23	3110-3123	periradicular	event[145]|object[146]	new[145]|giv[146]	coref	28-31[0_146]
25-24	3124-3131	tissues	event[145]|object[146]	new[145]|giv[146]	_	_
25-25	3132-3133	,	_	_	_	_
25-26	3134-3137	and	_	_	_	_
25-27	3138-3139	(	_	_	_	_
25-28	3140-3141	2	_	_	_	_
25-29	3142-3143	)	_	_	_	_
25-30	3144-3151	provide	_	_	_	_
25-31	3152-3153	a	abstract[147]	new[147]	_	_
25-32	3154-3171	three-dimensional	abstract[147]	new[147]	_	_
25-33	3172-3180	hermetic	abstract[147]	new[147]	_	_
25-34	3181-3185	seal	abstract[147]	new[147]	_	_
25-35	3186-3188	to	_	_	_	_
25-36	3189-3196	prevent	_	_	_	_
25-37	3197-3208	reinfection	event	new	_	_
25-38	3209-3210	.	_	_	_	_

#Text=Different hand and rotary instruments are used during RCT in order to mechanically debride the biofilm on the root canal walls .
26-1	3211-3220	Different	object[149]	new[149]	_	_
26-2	3221-3225	hand	object[149]	new[149]	_	_
26-3	3226-3229	and	_	_	_	_
26-4	3230-3236	rotary	abstract[150]	new[150]	coref	27-17[160_150]
26-5	3237-3248	instruments	abstract[150]	new[150]	_	_
26-6	3249-3252	are	_	_	_	_
26-7	3253-3257	used	_	_	_	_
26-8	3258-3264	during	_	_	_	_
26-9	3265-3268	RCT	event	giv	coref	31-23[194_0]
26-10	3269-3271	in	_	_	_	_
26-11	3272-3277	order	_	_	_	_
26-12	3278-3280	to	_	_	_	_
26-13	3281-3293	mechanically	_	_	_	_
26-14	3294-3301	debride	_	_	_	_
26-15	3302-3305	the	substance[152]	giv[152]	coref	32-42[0_152]
26-16	3306-3313	biofilm	substance[152]	giv[152]	_	_
26-17	3314-3316	on	substance[152]	giv[152]	_	_
26-18	3317-3320	the	substance[152]|object[154]	giv[152]|giv[154]	coref	28-11[168_154]
26-19	3321-3325	root	substance[152]|object[154]	giv[152]|giv[154]	_	_
26-20	3326-3331	canal	substance[152]|place|object[154]	giv[152]|giv|giv[154]	coref	27-6
26-21	3332-3337	walls	substance[152]|object[154]	giv[152]|giv[154]	_	_
26-22	3338-3339	.	_	_	_	_

#Text=Nevertheless , the cross-sectional root canal configuration can pose a challenge to adequate debridement , as these instruments tend to leave untouched recesses in oval canals .
27-1	3340-3352	Nevertheless	_	_	_	_
27-2	3353-3354	,	_	_	_	_
27-3	3355-3358	the	abstract[157]	new[157]	_	_
27-4	3359-3374	cross-sectional	abstract[157]	new[157]	_	_
27-5	3375-3379	root	plant|abstract[157]	giv|new[157]	coref	28-12
27-6	3380-3385	canal	place|abstract[157]	giv|new[157]	coref	28-13
27-7	3386-3399	configuration	abstract[157]	new[157]	_	_
27-8	3400-3403	can	_	_	_	_
27-9	3404-3408	pose	_	_	_	_
27-10	3409-3410	a	abstract[158]	new[158]	_	_
27-11	3411-3420	challenge	abstract[158]	new[158]	_	_
27-12	3421-3423	to	abstract[158]	new[158]	_	_
27-13	3424-3432	adequate	abstract[158]|abstract[159]	new[158]|new[159]	coref	31-11[190_159]
27-14	3433-3444	debridement	abstract[158]|abstract[159]	new[158]|new[159]	_	_
27-15	3445-3446	,	_	_	_	_
27-16	3447-3449	as	_	_	_	_
27-17	3450-3455	these	abstract[160]	giv[160]	_	_
27-18	3456-3467	instruments	abstract[160]	giv[160]	_	_
27-19	3468-3472	tend	_	_	_	_
27-20	3473-3475	to	_	_	_	_
27-21	3476-3481	leave	_	_	_	_
27-22	3482-3491	untouched	abstract[161]	new[161]	_	_
27-23	3492-3500	recesses	abstract[161]	new[161]	_	_
27-24	3501-3503	in	_	_	_	_
27-25	3504-3508	oval	place[162]	giv[162]	coref	37-47[268_162]
27-26	3509-3515	canals	place[162]	giv[162]	_	_
27-27	3516-3517	.	_	_	_	_

#Text=This instrumentation can however create a smear layer that covers the root canal walls , which consists of organic ( pulp tissue remnants ) and inorganic ( dentin chips ) tissues .
28-1	3518-3522	This	abstract[163]	new[163]	_	_
28-2	3523-3538	instrumentation	abstract[163]	new[163]	_	_
28-3	3539-3542	can	_	_	_	_
28-4	3543-3550	however	_	_	_	_
28-5	3551-3557	create	_	_	_	_
28-6	3558-3559	a	object[165]	new[165]	coref	29-1[175_165]
28-7	3560-3565	smear	substance|object[165]	new|new[165]	coref	31-18
28-8	3566-3571	layer	object[165]	new[165]	_	_
28-9	3572-3576	that	_	_	_	_
28-10	3577-3583	covers	_	_	_	_
28-11	3584-3587	the	object[168]	giv[168]	coref	29-14[178_168]
28-12	3588-3592	root	object|object[168]	giv|giv[168]	coref	31-11
28-13	3593-3598	canal	place|object[168]	giv|giv[168]	coref	29-15
28-14	3599-3604	walls	object[168]	giv[168]	_	_
28-15	3605-3606	,	_	_	_	_
28-16	3607-3612	which	_	_	_	_
28-17	3613-3621	consists	_	_	_	_
28-18	3622-3624	of	_	_	_	_
28-19	3625-3632	organic	object	new	appos	28-21[171_0]
28-20	3633-3634	(	_	_	_	_
28-21	3635-3639	pulp	object[171]	giv[171]	_	_
28-22	3640-3646	tissue	object|object[171]	giv|giv[171]	_	_
28-23	3647-3655	remnants	object[171]	giv[171]	_	_
28-24	3656-3657	)	_	_	_	_
28-25	3658-3661	and	_	_	_	_
28-26	3662-3671	inorganic	_	_	_	_
28-27	3672-3673	(	_	_	_	_
28-28	3674-3680	dentin	object|object[173]	giv|new[173]	_	_
28-29	3681-3686	chips	object[173]	new[173]	_	_
28-30	3687-3688	)	_	_	_	_
28-31	3689-3696	tissues	object	giv	_	_
28-32	3697-3698	.	_	_	_	_

#Text=This layer might act as a protective barrier to encase biofilms formed on root canal walls and might also encourage the adherence of microorganisms , such as C. albicans .
29-1	3699-3703	This	object[175]	giv[175]	coref	31-17[193_175]
29-2	3704-3709	layer	object[175]	giv[175]	_	_
29-3	3710-3715	might	_	_	_	_
29-4	3716-3719	act	_	_	_	_
29-5	3720-3722	as	_	_	_	_
29-6	3723-3724	a	_	_	_	_
29-7	3725-3735	protective	_	_	_	_
29-8	3736-3743	barrier	_	_	_	_
29-9	3744-3746	to	_	_	_	_
29-10	3747-3753	encase	_	_	_	_
29-11	3754-3762	biofilms	substance	new	_	_
29-12	3763-3769	formed	_	_	_	_
29-13	3770-3772	on	_	_	_	_
29-14	3773-3777	root	object[178]	giv[178]	_	_
29-15	3778-3783	canal	place|object[178]	giv|giv[178]	coref	30-10
29-16	3784-3789	walls	object[178]	giv[178]	_	_
29-17	3790-3793	and	_	_	_	_
29-18	3794-3799	might	_	_	_	_
29-19	3800-3804	also	_	_	_	_
29-20	3805-3814	encourage	_	_	_	_
29-21	3815-3818	the	abstract[179]	new[179]	ana	30-3[0_179]
29-22	3819-3828	adherence	abstract[179]	new[179]	_	_
29-23	3829-3831	of	abstract[179]	new[179]	_	_
29-24	3832-3846	microorganisms	abstract[179]|object	new[179]|giv	coref	34-15
29-25	3847-3848	,	abstract[179]	new[179]	_	_
29-26	3849-3853	such	abstract[179]	new[179]	_	_
29-27	3854-3856	as	abstract[179]	new[179]	_	_
29-28	3857-3859	C.	abstract[179]|plant[181]	new[179]|giv[181]	coref	33-17[219_181]
29-29	3860-3868	albicans	abstract[179]|plant[181]	new[179]|giv[181]	_	_
29-30	3869-3870	.	_	_	_	_

#Text=Furthermore , it may compromise the quality of root canal sealing .
30-1	3871-3882	Furthermore	_	_	_	_
30-2	3883-3884	,	_	_	_	_
30-3	3885-3887	it	abstract	giv	_	_
30-4	3888-3891	may	_	_	_	_
30-5	3892-3902	compromise	_	_	_	_
30-6	3903-3906	the	abstract[183]	new[183]	_	_
30-7	3907-3914	quality	abstract[183]	new[183]	_	_
30-8	3915-3917	of	abstract[183]	new[183]	_	_
30-9	3918-3922	root	abstract[183]|object[185]	new[183]|new[185]	_	_
30-10	3923-3928	canal	abstract[183]|place|object[185]	new[183]|giv|new[185]	coref	31-12
30-11	3929-3936	sealing	abstract[183]|object[185]	new[183]|new[185]	_	_
30-12	3937-3938	.	_	_	_	_

#Text=Therefore , the use of chemical irrigating solutions to maximise root canal debridement and removal of the smear layer is vital for successful RCT , which includes ethylenediaminetetraacetic acid ( EDTA ) , though not universally .
31-1	3939-3948	Therefore	_	_	_	_
31-2	3949-3950	,	_	_	_	_
31-3	3951-3954	the	abstract[186]	new[186]	_	_
31-4	3955-3958	use	abstract[186]	new[186]	_	_
31-5	3959-3961	of	abstract[186]	new[186]	_	_
31-6	3962-3970	chemical	abstract[186]|substance[187]	new[186]|new[187]	_	_
31-7	3971-3981	irrigating	abstract[186]|substance[187]	new[186]|new[187]	_	_
31-8	3982-3991	solutions	abstract[186]|substance[187]	new[186]|new[187]	_	_
31-9	3992-3994	to	_	_	_	_
31-10	3995-4003	maximise	_	_	_	_
31-11	4004-4008	root	plant|abstract[190]	giv|giv[190]	coref|coref	37-23|37-23
31-12	4009-4014	canal	place|abstract[190]	giv|giv[190]	coref	37-24
31-13	4015-4026	debridement	abstract[190]	giv[190]	_	_
31-14	4027-4030	and	_	_	_	_
31-15	4031-4038	removal	event[191]	new[191]	_	_
31-16	4039-4041	of	event[191]	new[191]	_	_
31-17	4042-4045	the	event[191]|object[193]	new[191]|giv[193]	coref	32-10[200_193]
31-18	4046-4051	smear	event[191]|substance|object[193]	new[191]|giv|giv[193]	coref	32-10
31-19	4052-4057	layer	event[191]|object[193]	new[191]|giv[193]	_	_
31-20	4058-4060	is	_	_	_	_
31-21	4061-4066	vital	_	_	_	_
31-22	4067-4070	for	_	_	_	_
31-23	4071-4081	successful	event[194]	giv[194]	coref	34-39[0_194]
31-24	4082-4085	RCT	event[194]	giv[194]	_	_
31-25	4086-4087	,	_	_	_	_
31-26	4088-4093	which	_	_	_	_
31-27	4094-4102	includes	_	_	_	_
31-28	4103-4129	ethylenediaminetetraacetic	abstract[195]	new[195]	appos	31-31[0_195]
31-29	4130-4134	acid	abstract[195]	new[195]	_	_
31-30	4135-4136	(	_	_	_	_
31-31	4137-4141	EDTA	abstract	giv	coref	32-1
31-32	4142-4143	)	_	_	_	_
31-33	4144-4145	,	_	_	_	_
31-34	4146-4152	though	_	_	_	_
31-35	4153-4156	not	_	_	_	_
31-36	4157-4168	universally	_	_	_	_
31-37	4169-4170	.	_	_	_	_

#Text=EDTA acts mainly as an adjunct irrigant to remove smear layer , though an alternative effect is the inhibition of filamentation through chelation of necessary divalent cations in the pathogenic yeast C. albicans , a structural element strongly associated with robust biofilm formation .
32-1	4171-4175	EDTA	substance|abstract[198]	giv|new[198]	coref|coref	37-9|37-9
32-2	4176-4180	acts	abstract[198]	new[198]	_	_
32-3	4181-4187	mainly	abstract[198]	new[198]	_	_
32-4	4188-4190	as	abstract[198]	new[198]	_	_
32-5	4191-4193	an	abstract[198]	new[198]	_	_
32-6	4194-4201	adjunct	abstract[198]	new[198]	_	_
32-7	4202-4210	irrigant	abstract[198]	new[198]	_	_
32-8	4211-4213	to	_	_	_	_
32-9	4214-4220	remove	_	_	_	_
32-10	4221-4226	smear	substance|object[200]	giv|giv[200]	_	_
32-11	4227-4232	layer	object[200]	giv[200]	_	_
32-12	4233-4234	,	_	_	_	_
32-13	4235-4241	though	_	_	_	_
32-14	4242-4244	an	event[201]	new[201]	coref	32-18[202_201]
32-15	4245-4256	alternative	event[201]	new[201]	_	_
32-16	4257-4263	effect	event[201]	new[201]	_	_
32-17	4264-4266	is	_	_	_	_
32-18	4267-4270	the	event[202]	giv[202]	_	_
32-19	4271-4281	inhibition	event[202]	giv[202]	_	_
32-20	4282-4284	of	event[202]	giv[202]	_	_
32-21	4285-4298	filamentation	event[202]|substance[203]	giv[202]|new[203]	_	_
32-22	4299-4306	through	event[202]|substance[203]	giv[202]|new[203]	_	_
32-23	4307-4316	chelation	event[202]|substance[203]|substance[204]	giv[202]|new[203]|new[204]	_	_
32-24	4317-4319	of	event[202]|substance[203]|substance[204]	giv[202]|new[203]|new[204]	_	_
32-25	4320-4329	necessary	event[202]|substance[203]|substance[204]|substance[206]	giv[202]|new[203]|new[204]|new[206]	_	_
32-26	4330-4338	divalent	event[202]|substance[203]|substance[204]|abstract|substance[206]	giv[202]|new[203]|new[204]|new|new[206]	_	_
32-27	4339-4346	cations	event[202]|substance[203]|substance[204]|substance[206]	giv[202]|new[203]|new[204]|new[206]	_	_
32-28	4347-4349	in	event[202]|substance[203]|substance[204]|substance[206]	giv[202]|new[203]|new[204]|new[206]	_	_
32-29	4350-4353	the	event[202]|substance[203]|substance[204]|substance[206]|substance[207]	giv[202]|new[203]|new[204]|new[206]|giv[207]	coref	36-4[240_207]
32-30	4354-4364	pathogenic	event[202]|substance[203]|substance[204]|substance[206]|substance[207]	giv[202]|new[203]|new[204]|new[206]|giv[207]	_	_
32-31	4365-4370	yeast	event[202]|substance[203]|substance[204]|substance[206]|substance[207]	giv[202]|new[203]|new[204]|new[206]|giv[207]	_	_
32-32	4371-4373	C.	_	_	_	_
32-33	4374-4382	albicans	_	_	_	_
32-34	4383-4384	,	_	_	_	_
32-35	4385-4386	a	abstract[208]	new[208]	_	_
32-36	4387-4397	structural	abstract[208]	new[208]	_	_
32-37	4398-4405	element	abstract[208]	new[208]	_	_
32-38	4406-4414	strongly	_	_	_	_
32-39	4415-4425	associated	_	_	_	_
32-40	4426-4430	with	_	_	_	_
32-41	4431-4437	robust	abstract[210]	new[210]	_	_
32-42	4438-4445	biofilm	substance|abstract[210]	giv|new[210]	coref	33-12
32-43	4446-4455	formation	abstract[210]	new[210]	_	_
32-44	4456-4457	.	_	_	_	_

#Text=Recent work from our group has highlighted the clinical relevance of biofilm heterogeneity between isolates of C. albicans from the oral cavity and other clinical sites .
33-1	4458-4464	Recent	abstract[211]	new[211]	_	_
33-2	4465-4469	work	abstract[211]	new[211]	_	_
33-3	4470-4474	from	abstract[211]	new[211]	_	_
33-4	4475-4478	our	abstract[211]|person|organization[213]	new[211]|acc|new[213]	ana|ana	35-1|35-1
33-5	4479-4484	group	abstract[211]|organization[213]	new[211]|new[213]	_	_
33-6	4485-4488	has	_	_	_	_
33-7	4489-4500	highlighted	_	_	_	_
33-8	4501-4504	the	abstract[214]	new[214]	_	_
33-9	4505-4513	clinical	abstract[214]	new[214]	_	_
33-10	4514-4523	relevance	abstract[214]	new[214]	_	_
33-11	4524-4526	of	abstract[214]	new[214]	_	_
33-12	4527-4534	biofilm	abstract[214]|substance|abstract[216]	new[214]|giv|new[216]	coref|coref|coref|coref	35-10|37-34[265_216]|35-10|37-34[265_216]
33-13	4535-4548	heterogeneity	abstract[214]|abstract[216]	new[214]|new[216]	_	_
33-14	4549-4556	between	abstract[214]|abstract[216]	new[214]|new[216]	_	_
33-15	4557-4565	isolates	abstract[214]|abstract[216]|object[217]	new[214]|new[216]|new[217]	_	_
33-16	4566-4568	of	abstract[214]|abstract[216]|object[217]	new[214]|new[216]|new[217]	_	_
33-17	4569-4571	C.	abstract[214]|abstract[216]|object[217]|person|substance[219]	new[214]|new[216]|new[217]|giv|giv[219]	coref|coref|coref|coref	36-12|37-28[263_219]|36-12|37-28[263_219]
33-18	4572-4580	albicans	abstract[214]|abstract[216]|object[217]|substance[219]	new[214]|new[216]|new[217]|giv[219]	_	_
33-19	4581-4585	from	abstract[214]|abstract[216]|object[217]	new[214]|new[216]|new[217]	_	_
33-20	4586-4589	the	abstract[214]|abstract[216]|object[217]|place[220]	new[214]|new[216]|new[217]|new[220]	ana	34-33[0_220]
33-21	4590-4594	oral	abstract[214]|abstract[216]|object[217]|place[220]	new[214]|new[216]|new[217]|new[220]	_	_
33-22	4595-4601	cavity	abstract[214]|abstract[216]|object[217]|place[220]	new[214]|new[216]|new[217]|new[220]	_	_
33-23	4602-4605	and	abstract[214]|abstract[216]|object[217]	new[214]|new[216]|new[217]	_	_
33-24	4606-4611	other	abstract[214]|abstract[216]|object[217]|place[221]	new[214]|new[216]|new[217]|new[221]	ana	34-17[0_221]
33-25	4612-4620	clinical	abstract[214]|abstract[216]|object[217]|place[221]	new[214]|new[216]|new[217]|new[221]	_	_
33-26	4621-4626	sites	abstract[214]|abstract[216]|object[217]|place[221]	new[214]|new[216]|new[217]|new[221]	_	_
33-27	4627-4628	.	_	_	_	_

#Text=The overriding message from this review is that with respect to particular groups of microorganisms , they cannot all be considered as a single entity and “ one size does not fit all ” when it comes to treatment regimens .
34-1	4629-4632	The	abstract[222]	new[222]	_	_
34-2	4633-4643	overriding	abstract[222]	new[222]	_	_
34-3	4644-4651	message	abstract[222]	new[222]	_	_
34-4	4652-4656	from	abstract[222]	new[222]	_	_
34-5	4657-4661	this	abstract[222]|abstract[223]	new[222]|new[223]	_	_
34-6	4662-4668	review	abstract[222]|abstract[223]	new[222]|new[223]	_	_
34-7	4669-4671	is	_	_	_	_
34-8	4672-4676	that	_	_	_	_
34-9	4677-4681	with	_	_	_	_
34-10	4682-4689	respect	abstract[224]	new[224]	_	_
34-11	4690-4692	to	abstract[224]	new[224]	_	_
34-12	4693-4703	particular	abstract[224]|animal[225]	new[224]|new[225]	_	_
34-13	4704-4710	groups	abstract[224]|animal[225]	new[224]|new[225]	_	_
34-14	4711-4713	of	abstract[224]|animal[225]	new[224]|new[225]	_	_
34-15	4714-4728	microorganisms	abstract[224]|animal[225]|object	new[224]|new[225]|giv	_	_
34-16	4729-4730	,	_	_	_	_
34-17	4731-4735	they	place	giv	_	_
34-18	4736-4742	cannot	_	_	_	_
34-19	4743-4746	all	_	_	_	_
34-20	4747-4749	be	_	_	_	_
34-21	4750-4760	considered	_	_	_	_
34-22	4761-4763	as	_	_	_	_
34-23	4764-4765	a	_	_	_	_
34-24	4766-4772	single	_	_	_	_
34-25	4773-4779	entity	_	_	_	_
34-26	4780-4783	and	_	_	_	_
34-27	4784-4785	“	_	_	_	_
34-28	4786-4789	one	quantity[228]	new[228]	_	_
34-29	4790-4794	size	quantity[228]	new[228]	_	_
34-30	4795-4799	does	_	_	_	_
34-31	4800-4803	not	_	_	_	_
34-32	4804-4807	fit	_	_	_	_
34-33	4808-4811	all	place	giv	ana	34-36
34-34	4812-4813	”	_	_	_	_
34-35	4814-4818	when	_	_	_	_
34-36	4819-4821	it	place	giv	_	_
34-37	4822-4827	comes	_	_	_	_
34-38	4828-4830	to	_	_	_	_
34-39	4831-4840	treatment	event|abstract[232]	giv|new[232]	coref|coref	37-25|37-25
34-40	4841-4849	regimens	abstract[232]	new[232]	_	_
34-41	4850-4851	.	_	_	_	_

#Text=We have shown that the greater capacity to form biofilm is linked to enhanced virulence and increased resistance to antifungals .
35-1	4852-4854	We	person	giv	ana	37-20
35-2	4855-4859	have	_	_	_	_
35-3	4860-4865	shown	_	_	_	_
35-4	4866-4870	that	_	_	_	_
35-5	4871-4874	the	abstract[234]	giv[234]	coref	37-38[266_234]
35-6	4875-4882	greater	abstract[234]	giv[234]	_	_
35-7	4883-4891	capacity	abstract[234]	giv[234]	_	_
35-8	4892-4894	to	_	_	_	_
35-9	4895-4899	form	_	_	_	_
35-10	4900-4907	biofilm	substance	giv	coref	37-34
35-11	4908-4910	is	_	_	_	_
35-12	4911-4917	linked	_	_	_	_
35-13	4918-4920	to	_	_	_	_
35-14	4921-4929	enhanced	abstract[236]	new[236]	_	_
35-15	4930-4939	virulence	abstract[236]	new[236]	_	_
35-16	4940-4943	and	_	_	_	_
35-17	4944-4953	increased	abstract[237]	new[237]	coref	36-21[0_237]
35-18	4954-4964	resistance	abstract[237]	new[237]	_	_
35-19	4965-4967	to	abstract[237]	new[237]	_	_
35-20	4968-4979	antifungals	abstract[237]|substance	new[237]|new	_	_
35-21	4980-4981	.	_	_	_	_

#Text=Further studies of this yeast , alongside the emerging yeast pathogen C. auris , have demonstrated that biofilm-mediated patterns of resistance also exist for both antiseptics and disinfectants , including sodium hypochlorite .
36-1	4982-4989	Further	event[239]	new[239]	_	_
36-2	4990-4997	studies	event[239]	new[239]	_	_
36-3	4998-5000	of	event[239]	new[239]	_	_
36-4	5001-5005	this	event[239]|substance[240]	new[239]|giv[240]	coref	36-10[0_240]
36-5	5006-5011	yeast	event[239]|substance[240]	new[239]|giv[240]	_	_
36-6	5012-5013	,	event[239]	new[239]	_	_
36-7	5014-5023	alongside	event[239]	new[239]	_	_
36-8	5024-5027	the	event[239]|plant[242]	new[239]|new[242]	_	_
36-9	5028-5036	emerging	event[239]|plant[242]	new[239]|new[242]	_	_
36-10	5037-5042	yeast	event[239]|substance|plant[242]	new[239]|giv|new[242]	_	_
36-11	5043-5051	pathogen	event[239]|plant[242]	new[239]|new[242]	_	_
36-12	5052-5054	C.	event[239]|plant[242]|person	new[239]|new[242]|giv	coref	37-28
36-13	5055-5060	auris	event[239]|plant[242]	new[239]|new[242]	_	_
36-14	5061-5062	,	_	_	_	_
36-15	5063-5067	have	_	_	_	_
36-16	5068-5080	demonstrated	_	_	_	_
36-17	5081-5085	that	_	_	_	_
36-18	5086-5102	biofilm-mediated	abstract[244]	new[244]	_	_
36-19	5103-5111	patterns	abstract[244]	new[244]	_	_
36-20	5112-5114	of	abstract[244]	new[244]	_	_
36-21	5115-5125	resistance	abstract[244]|abstract	new[244]|giv	_	_
36-22	5126-5130	also	_	_	_	_
36-23	5131-5136	exist	_	_	_	_
36-24	5137-5140	for	_	_	_	_
36-25	5141-5145	both	substance[246]	new[246]	_	_
36-26	5146-5157	antiseptics	substance[246]	new[246]	_	_
36-27	5158-5161	and	_	_	_	_
36-28	5162-5175	disinfectants	substance[247]	new[247]	_	_
36-29	5176-5177	,	substance[247]	new[247]	_	_
36-30	5178-5187	including	substance[247]	new[247]	_	_
36-31	5188-5194	sodium	substance[247]|substance|substance[249]	new[247]|new|new[249]	coref|coref|coref|coref	37-3|37-2[251_249]|37-3|37-2[251_249]
36-32	5195-5207	hypochlorite	substance[247]|substance[249]	new[247]|new[249]	_	_
36-33	5208-5209	.	_	_	_	_

#Text=Given that sodium hypochlorite ( NaOCl ) and EDTA are principal components of the management of endodontic infections , we hypothesised that root canal treatment failure involving C. albicans may be driven by biofilm heterogeneity resulting in an enhanced ability to withstand treatment and regrow within root canals .
37-1	5210-5215	Given	_	_	_	_
37-2	5216-5220	that	substance[251]	giv[251]	appos	37-6[0_251]
37-3	5221-5227	sodium	substance|substance[251]	giv|giv[251]	_	_
37-4	5228-5240	hypochlorite	substance[251]	giv[251]	_	_
37-5	5241-5242	(	_	_	_	_
37-6	5243-5248	NaOCl	substance	giv	coref	38-14
37-7	5249-5250	)	_	_	_	_
37-8	5251-5254	and	_	_	_	_
37-9	5255-5259	EDTA	abstract	giv	coref	37-11[254_0]
37-10	5260-5263	are	_	_	_	_
37-11	5264-5273	principal	abstract[254]	giv[254]	coref	38-16[0_254]
37-12	5274-5284	components	abstract[254]	giv[254]	_	_
37-13	5285-5287	of	abstract[254]	giv[254]	_	_
37-14	5288-5291	the	abstract[254]|event[255]	giv[254]|new[255]	_	_
37-15	5292-5302	management	abstract[254]|event[255]	giv[254]|new[255]	_	_
37-16	5303-5305	of	abstract[254]|event[255]	giv[254]|new[255]	_	_
37-17	5306-5316	endodontic	abstract[254]|event[255]|event[256]	giv[254]|new[255]|giv[256]	_	_
37-18	5317-5327	infections	abstract[254]|event[255]|event[256]	giv[254]|new[255]|giv[256]	_	_
37-19	5328-5329	,	_	_	_	_
37-20	5330-5332	we	person	giv	ana	38-1
37-21	5333-5345	hypothesised	_	_	_	_
37-22	5346-5350	that	_	_	_	_
37-23	5351-5355	root	object|abstract[261]	giv|new[261]	_	_
37-24	5356-5361	canal	place|abstract[261]	giv|new[261]	_	_
37-25	5362-5371	treatment	event|abstract[261]	giv|new[261]	coref	37-43
37-26	5372-5379	failure	abstract[261]	new[261]	_	_
37-27	5380-5389	involving	_	_	_	_
37-28	5390-5392	C.	person|substance[263]	giv|giv[263]	_	_
37-29	5393-5401	albicans	substance[263]	giv[263]	_	_
37-30	5402-5405	may	_	_	_	_
37-31	5406-5408	be	_	_	_	_
37-32	5409-5415	driven	_	_	_	_
37-33	5416-5418	by	_	_	_	_
37-34	5419-5426	biofilm	substance|abstract[265]	giv|giv[265]	coref|coref	38-8|38-8
37-35	5427-5440	heterogeneity	abstract[265]	giv[265]	_	_
37-36	5441-5450	resulting	_	_	_	_
37-37	5451-5453	in	_	_	_	_
37-38	5454-5456	an	abstract[266]	giv[266]	_	_
37-39	5457-5465	enhanced	abstract[266]	giv[266]	_	_
37-40	5466-5473	ability	abstract[266]	giv[266]	_	_
37-41	5474-5476	to	_	_	_	_
37-42	5477-5486	withstand	_	_	_	_
37-43	5487-5496	treatment	event	giv	_	_
37-44	5497-5500	and	_	_	_	_
37-45	5501-5507	regrow	_	_	_	_
37-46	5508-5514	within	_	_	_	_
37-47	5515-5519	root	place[268]	giv[268]	_	_
37-48	5520-5526	canals	place[268]	giv[268]	_	_
37-49	5527-5528	.	_	_	_	_

#Text=We therefore aimed to assess how different biofilm phenotypes responded in vitro to NaOCl and EDTA treatments .
38-1	5529-5531	We	person	giv	_	_
38-2	5532-5541	therefore	_	_	_	_
38-3	5542-5547	aimed	_	_	_	_
38-4	5548-5550	to	_	_	_	_
38-5	5551-5557	assess	_	_	_	_
38-6	5558-5561	how	_	_	_	_
38-7	5562-5571	different	abstract[271]	new[271]	_	_
38-8	5572-5579	biofilm	substance|abstract[271]	giv|new[271]	_	_
38-9	5580-5590	phenotypes	abstract[271]	new[271]	_	_
38-10	5591-5600	responded	_	_	_	_
38-11	5601-5603	in	_	_	_	_
38-12	5604-5609	vitro	_	_	_	_
38-13	5610-5612	to	_	_	_	_
38-14	5613-5618	NaOCl	substance|abstract[274]	giv|new[274]	_	_
38-15	5619-5622	and	abstract[274]	new[274]	_	_
38-16	5623-5627	EDTA	abstract|abstract[274]	giv|new[274]	_	_
38-17	5628-5638	treatments	abstract[274]	new[274]	_	_
38-18	5639-5640	.	_	_	_	_
